Compile Data Set for Download or QSAR
Report error Found 186 Enz. Inhib. hit(s) with all data for entry = 3330
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31501(substituted biphenyl derivative, 36ao)
Affinity DataIC50: 8nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31462(substituted biphenyl derivative, 36b)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31468(substituted biphenyl derivative, 36h)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31488(substituted biphenyl derivative, 36ab)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31497(substituted biphenyl derivative, 36ak)
Affinity DataIC50: 9nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31499(substituted biphenyl derivative, 36am)
Affinity DataIC50: 9nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31486(substituted biphenyl derivative, 36z)
Affinity DataIC50: 10nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31487(substituted biphenyl derivative, 36aa)
Affinity DataIC50: 10nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31500(substituted biphenyl derivative, 36an)
Affinity DataIC50: 10nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31470(substituted biphenyl derivative, 36j)
Affinity DataIC50: 11nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31489(substituted biphenyl derivative, 36ac)
Affinity DataIC50: 11nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31493(substituted biphenyl derivative, 36ag)
Affinity DataIC50: 11nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31474(substituted biphenyl derivative, 36n)
Affinity DataIC50: 12nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31467(substituted biphenyl derivative, 36g)
Affinity DataIC50: 13nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31490(substituted biphenyl derivative, 36ad)
Affinity DataIC50: 14nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31502(substituted biphenyl derivative, 36ap)
Affinity DataIC50: 20nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31501(substituted biphenyl derivative, 36ao)
Affinity DataIC50: 20nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31483(substituted biphenyl derivative, 36w)
Affinity DataIC50: 21nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31503(substituted biphenyl derivative, 36aq)
Affinity DataIC50: 24nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31466(substituted biphenyl derivative, 36f)
Affinity DataIC50: 25nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31475(substituted biphenyl derivative, 36o)
Affinity DataIC50: 29nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31461(substituted biphenyl derivative, 24)
Affinity DataIC50: 30nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31500(substituted biphenyl derivative, 36an)
Affinity DataIC50: 33nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31469(substituted biphenyl derivative, 36i)
Affinity DataIC50: 34nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31487(substituted biphenyl derivative, 36aa)
Affinity DataIC50: 35nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31495(substituted biphenyl derivative, 36ai)
Affinity DataIC50: 36nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31487(substituted biphenyl derivative, 36aa)
Affinity DataIC50: 40nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31464(substituted biphenyl derivative, 36d)
Affinity DataIC50: 42nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31471(substituted biphenyl derivative, 36k)
Affinity DataIC50: 45nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31490(substituted biphenyl derivative, 36ad)
Affinity DataIC50: 50nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31491(substituted biphenyl derivative, 36ae)
Affinity DataIC50: 50nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31499(substituted biphenyl derivative, 36am)
Affinity DataIC50: 50nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31473(substituted biphenyl derivative, 36m)
Affinity DataIC50: 52nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31480(substituted biphenyl derivative, 36t)
Affinity DataIC50: 60nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31497(substituted biphenyl derivative, 36ak)
Affinity DataIC50: 60nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31460(substituted biphenyl derivative, 36a)
Affinity DataIC50: 67nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31467(substituted biphenyl derivative, 36g)
Affinity DataIC50: 70nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31491(substituted biphenyl derivative, 36ae)
Affinity DataIC50: 76nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31465(substituted biphenyl derivative, 36e)
Affinity DataIC50: 92nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31463(substituted biphenyl derivative, 36c)
Affinity DataIC50: 97nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31482(substituted biphenyl derivative, 36v)
Affinity DataIC50: 98nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31492(substituted biphenyl derivative, 36af)
Affinity DataIC50: 104nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31459(CHEMBL224485 | substituted biphenyl derivative, 21)
Affinity DataIC50: 120nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31489(substituted biphenyl derivative, 36ac)
Affinity DataIC50: 120nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31469(substituted biphenyl derivative, 36i)
Affinity DataIC50: 127nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31472(substituted biphenyl derivative, 36l)
Affinity DataIC50: 130nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31497(substituted biphenyl derivative, 36ak)
Affinity DataIC50: 130nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31486(substituted biphenyl derivative, 36z)
Affinity DataIC50: 150nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31503(substituted biphenyl derivative, 36aq)
Affinity DataIC50: 150nMT: 2°CAssay Description:Thrombin assay reactions were performed in a reaction mixture containing thrombin, and test compounds were added at varied concentrations. The reacti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31488(substituted biphenyl derivative, 36ab)
Affinity DataIC50: 163nMT: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 186 total ) | Next | Last >>
Jump to: